Success Metrics

Clinical Success Rate
66.7%

Based on 4 completed trials

Completion Rate
67%(4/6)
Active Trials
1(13%)
Results Posted
0%(0 trials)
Terminated
2(25%)

Phase Distribution

Ph phase_2
4
50%
Ph phase_1
2
25%
Ph not_applicable
2
25%

Phase Distribution

2

Early Stage

4

Mid Stage

0

Late Stage

Phase Distribution8 total trials
Phase 1Safety & dosage
2(25.0%)
Phase 2Efficacy & side effects
4(50.0%)
N/ANon-phased studies
2(25.0%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

66.7%

4 of 6 finished

Non-Completion Rate

33.3%

2 ended early

Currently Active

1

trials recruiting

Total Trials

8

all time

Status Distribution
Active(1)
Completed(4)
Terminated(2)
Other(1)

Detailed Status

Completed4
Terminated2
unknown1
Active, not recruiting1

Development Timeline

Analytics

Development Status

Total Trials
8
Active
1
Success Rate
66.7%
Most Advanced
Phase 2

Trials by Phase

Phase 12 (25.0%)
Phase 24 (50.0%)
N/A2 (25.0%)

Trials by Status

unknown113%
completed450%
active_not_recruiting113%
terminated225%

Recent Activity

1 active trials
Showing 5 of 8
active_not_recruitingnot_applicable

Bond Strength Evaluation

NCT07196618
completednot_applicable

Clinical Evaluation of Dimethyl Sulfoxide Dentin Pre-treatment

NCT04492306
completedphase_2

Acceleration of Orthodontic Tooth Movement

NCT05560919
completedphase_2

Melatonin Cream Against Acute Radiation Dermatitis in Patients With Early Breast Cancer

NCT03716583
completedphase_1

Vaccine Therapy With or Without Imiquimod in Treating Patients Who Have Undergone Surgery for Stage II, Stage III, or Stage IV Melanoma

NCT00118313
View all 8 trials

Clinical Trials (8)

Showing 8 of 8 trials
NCT07196618Not Applicable

Bond Strength Evaluation

Active Not Recruiting
NCT04492306Not Applicable

Clinical Evaluation of Dimethyl Sulfoxide Dentin Pre-treatment

Completed
NCT05560919Phase 2

Acceleration of Orthodontic Tooth Movement

Completed
NCT03716583Phase 2

Melatonin Cream Against Acute Radiation Dermatitis in Patients With Early Breast Cancer

Completed
NCT00118313Phase 1

Vaccine Therapy With or Without Imiquimod in Treating Patients Who Have Undergone Surgery for Stage II, Stage III, or Stage IV Melanoma

Completed
NCT01123915Phase 1

A Safety and Immunogenicity Study of 3 Doses of Opal Immunotherapy in HIV Infected People

Terminated
NCT02206477Phase 2

DMSO for Prevention of Capsular Contraction in Alloplastic Breast Reconstruction

Unknown
NCT00317070Phase 2

Trial Comparing Intravesical Cocktail With Intravesical Dimethyl Sulfoxide (DMSO) in Painful Bladder Syndrome/Interstitial Cystitis (PBS/IC)

Terminated

All 8 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
8